Skip to content

SONNET BIOTHERAPEUTICS HOLDINGS, INC.

CIK 0001106838

← back to feed
Revenue (TTM)
$1.09M
+5,268.8% YoY FY Dec 2025
Net Income (TTM)
−$13.93M
−115.3% YoY FY Dec 2025
EPS Diluted (TTM)
−$8.97
+65.2% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
-1,320.1%
FY Dec 2025
Net Margin
-1,276.0%
FY Dec 2025
Free Cash Flow (TTM)
−$20.55M
FY Dec 2025
Cash
$5.12M
FY Dec 2025
Total Debt
$3.21M
FY Dec 2025
Shares Outstanding
1 sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings